GRHL1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA005798

Antibody HPA006420

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most malignancies were negative or showed weak cytoplasmic or nuclear immunoreactivity. Several skin- and urothelial cancers displayed moderate to strong nuclear staining in a fraction of cells.Moderate cytoplasmic staining in most prostate cancers, weak and diffuse either cytoplasmic or nuclear staining in a few cases of several malignancies. Strong nuclear positivity in a few urothelial cancers. Virtually no staining in other malignancies.

Validation

Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Supportive: Two (or more) antibodies yielding partly similar staining patterns which are consistent with gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected